Skip to main content

Advertisement

SpringerLink
Log in

Platelet recruitment to venous stent thrombi

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Thrombosis following venous stent placement is a morbid clinical outcome. Whether to target platelets or coagulation factors for venous stent thromboprophylaxis remains unclear. We sought to determine whether integrin αIIbβ3 antagonism with lamifiban would inhibit platelet recruitment to venous stent thrombosis. Anti-thrombotic efficacy was compared between venous and arterial circulations. Pigs received either lamifiban (0.2 mg/kg bolus plus 0.2 mg/kg/h infusion; n = 6) or saline (n = 12). Carotid arteries were crush injured and then harvested 30 min later to provide an assessment of antithrombotic efficacy in the arterial circulation. Iliac venous stents were then deployed and thrombi allowed to propagate for 2 h before harvesting. Platelet deposition was measured by scintillation detection of autologous 111In-platelets. Venous thrombi were quantified by weight and compared to platelet, Von Willebrand factor (VWF) and fibrinogen content. Arterial platelet deposition (×106/cm2) was reduced >80 % by lamifiban (398 ± 437) compared to controls (1,540 ± 883; p < 0.005). Lamifiban also reduced venous thrombus platelet deposition (139 ± 88 vs. 281 ± 167) however did not prevent thrombosis. In control animals, venous stent platelet deposition correlated with plasma fibrinogen content (R2 = 0.29; p = 0.03). Fibrinogen content correlated directly with venous stent platelet deposition (p = 0.03) but not thrombus weight. Neither venous platelet deposition nor thrombus weights varied by VWF content. Platelet recruitment to venous stent thrombi occurs in part through the integrin αIIbβ3 receptor. Unlike arterial thrombosis, inhibition of this receptor is insufficient to prevent venous stent thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mewissen MW, Seabrook GR, Meissner MH et al (1999) Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 211:39–49

    Article  PubMed  CAS  Google Scholar 

  2. AbuRahma AF, Perkins SE, Wulu JT et al (2001) Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 233:752–760

    Article  PubMed  CAS  Google Scholar 

  3. Vedantham S, Vesely TM, Sicard GA et al (2004) Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 15:565–574

    Article  PubMed  Google Scholar 

  4. Augustinos P, Ouriel K (2004) Invasive approaches to treatment of venous thromboembolism. Circulation 110:I27–I134

    Article  PubMed  Google Scholar 

  5. Thomas IH, Zierler BK (2005) An integrative review of outcomes in patients with acute primary upper extremity deep venous thrombosis following no treatment or treatment with anticoagulation, thrombolysis, or surgical algorithms. Vasc Endovasc Surg 39:163–174

    Article  Google Scholar 

  6. Mickley V, Gorich J, Rilinger N et al (1997) Stenting of central venous stenoses in hemodialysis patients: long-term results. Kidney Int 51:277–280

    Article  PubMed  CAS  Google Scholar 

  7. Blattler W, Blattler IK (1999) Relief of obstructive pelvic venous symptoms with endoluminal stenting. J Vasc Surg 29:484–488

    Article  PubMed  CAS  Google Scholar 

  8. Enden T, Kløw NE, Sandvik L et al (2009) Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 7:1268–1275

    Article  PubMed  CAS  Google Scholar 

  9. Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM (2012) Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis: a randomised controlled trial. Lancet 379:31–38

    Article  PubMed  Google Scholar 

  10. Coleman RW, Clowes AW, George JN et al (2006) Overview of hemostasis. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ (eds) Hemostasis and thrombosis, 5th edn. Lipincott Williams and Wilkins, Philadelphia, pp 3–16

    Google Scholar 

  11. Sevitt S (1974) The structure and growth of valve-pocket thrombi in femoral veins. J Clin Pathol 27:517–528

    Article  PubMed  CAS  Google Scholar 

  12. Malone PC (1977) A hypothesis concerning the aetiology of venous thrombosis. Med Hypothal 3:189–201

    Article  CAS  Google Scholar 

  13. Ruiz-Irastorza G, Crowther M, Branch W et al (2010) Antiphospholipid syndrome. Lancet 3:1–12

    Google Scholar 

  14. Greinacher A, Warkentin TE (2006) Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res 118:165–176

    Article  PubMed  CAS  Google Scholar 

  15. Hovinga JAK, Vesely SK, Terrell DR et al (2010) Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 115:1500–1511

    Article  Google Scholar 

  16. Gruppo Italiano Studio (1995) Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Ann Intern Med 123:656–664

    Article  Google Scholar 

  17. Cortelazzo S, Viero P, Finazzi G et al (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556–562

    PubMed  CAS  Google Scholar 

  18. Burches B, Karnicki K, Wysokinski W et al (2006) Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis. Thromb Haemost 96:618–622

    PubMed  CAS  Google Scholar 

  19. Wysokinski W, Karnicki K, McBane RD 2nd (2008) Individual propensity for thrombosis: comparison of venous and arterial circulations. Thromb Res 122(3):390–396

    Article  PubMed  CAS  Google Scholar 

  20. McBane RD 2nd, Leadley RJ Jr, Baxi SM et al (2008) Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs. Arterioscler Thromb Vasc Biol 28:413–418

    Article  PubMed  CAS  Google Scholar 

  21. Knight LC, Romano JE, Maurer AH (1998) In vitro platelet binding compared with in vivo thrombus imaging using alpha(IIb)beta3-targeted radioligands. Thromb Haemost 80:845–851

    PubMed  CAS  Google Scholar 

  22. Alig L, Edenhofer A, Hadvary P et al (1992) Low molecular weight, non-peptide fibrinogen receptor antagonists. J Med Chem 35:4393–4407

    Article  PubMed  CAS  Google Scholar 

  23. Kouns WC, Kirchhofer D, Hadvary P et al (1992) Reversible conformational changes induced in glycoprotein IIb/IIIa by a potent and selective peptidomimetic inhibitor. Blood 80:2539–2547

    PubMed  CAS  Google Scholar 

  24. Chico TJ, Chamberlain J, Gunn J et al (2001) Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty. Circulation 103:1135–1141

    Article  PubMed  CAS  Google Scholar 

  25. McBane RD, Wysokinski WE, Chesebro JH et al (1995) Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation. Thromb Haemost 74:879–885

    PubMed  CAS  Google Scholar 

  26. Posan E, McBane RD, Grill DE et al (2003) Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost 90:483–490

    PubMed  CAS  Google Scholar 

  27. Rossi E, Mondonico P, Lombardi A et al (1988) Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 52:453–468

    Article  PubMed  CAS  Google Scholar 

  28. Eby C, Chance D, Oliver D (1997) A multicenter evaluation of STA-LIATEST VWF: a new latex particle immunoassay for von Willebrand factor antigen. Clin Hemost Rev 11:16–17

    Google Scholar 

  29. Pruthi RK, Daniels TM, Heit JA et al (2010) Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging. Thromb Res 126:543–549

    Article  PubMed  CAS  Google Scholar 

  30. Budde U, Schneppenheim R, Eikenboom J et al (2008) Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost 6:762–771

    Article  PubMed  CAS  Google Scholar 

  31. Knight LC, Romano JE, Maurer AH (1998) In vitro platelet binding compared with in vivo thrombus imaging using alpha(IIb)beta3-targeted radioligands. Thromb Haemost 80:845–851

    PubMed  CAS  Google Scholar 

  32. Herbert JM, Bernat A, Maffrand JP (1992) Importance of platelets in experimental venous thrombosis in the rat. Blood 80:2281–2286

    PubMed  CAS  Google Scholar 

  33. Chauhan AK, Kisucka J, Lamb CB et al (2007) von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins. Blood 109:2424–2429

    Article  PubMed  CAS  Google Scholar 

  34. Brill A, Fuchs TA, Chauhan AK, et al (2011) von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 117:1400–1407

    Google Scholar 

  35. Lopez JA, Dong JF (2004) Cleavage of von Willebrand factor by ADAMTS13 on endothelial cells. Semin Hematol 41:15–23

    Article  PubMed  CAS  Google Scholar 

  36. Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P, WARFASA Investigators (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959–1967

    Article  PubMed  CAS  Google Scholar 

  37. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J, ASPIRE Investigators (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979–1987

    Article  PubMed  CAS  Google Scholar 

  38. Kageyama K, Nakajima Y, Shibasaki M et al (2007) Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty. J Thromb Haemost 5:738–745

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

The authors have no disclosures to make regarding this manuscript.

Author information

Authors and Affiliations

  1. Section of Hematology Research, Mayo Clinic, Rochester, MN, 55905, USA

    Robert D. McBane II, Krzysztof Karnicki & Waldemar E. Wysokinski

  2. Division of Cardiology, Mayo Clinic, Rochester, MN, 55905, USA

    Robert D. McBane II & Waldemar E. Wysokinski

  3. Division of Cardiovascular Medicine, Mayo Clinic, 200 First Street, Rochester, MN, 55905, USA

    Robert D. McBane II

Authors
  1. Robert D. McBane II
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krzysztof Karnicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Waldemar E. Wysokinski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert D. McBane II.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McBane, R.D., Karnicki, K. & Wysokinski, W.E. Platelet recruitment to venous stent thrombi. J Thromb Thrombolysis 36, 442–447 (2013). https://doi.org/10.1007/s11239-013-0924-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-013-0924-x

Keywords

Search

Navigation